Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies-Reference-Cited by-同舟云学术

Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies

Published:2018-10-04 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Roncato Francesco,Rruga Fatlum^ORCID,Porcù Elena,Casarin Elisabetta,Ronca Roberto^ORCID,Maccarinelli Federica,Realdon Nicola,Basso Giuseppe,Alon Ronen,Viola Giampietro^ORCID,Morpurgo Margherita^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-06602-6.pdf

Reference43 articles.

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

2. Merten, H., Brandl, F., Pluckthun, A. & Zangemeister-Wittke, U. Antibody− drug conjugates for tumor targeting-novel conjugation chemistries and the promise ofnon-IgG binding proteins. Bioconjug. Chem. 26, 2176–2185 (2015).

3. Ducry, L. & Stump, B. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies. Bioconjug. Chem. 21, 5–13 (2010).

4. Perez, H. L. et al. Antibody-drug conjugates: current status and future directions. Drug Discov. Today 19, 869–881 (2014).

5. Sapra, P. et al. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys. Clin. Cancer Res. 11, 5257–5264 (2005).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface engineering of metal-organic framework nanoparticles-based miRNA carrier: Boosting RNA stability, intracellular delivery and synergistic therapy;Journal of Colloid and Interface Science;2025-01

2. A novel mertansine conjugate for acid-reversible targeted drug delivery validated through the Avidin-Nucleic-Acid-NanoASsembly platform;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11

3. Self-reporting photodynamic nanobody conjugate for precise and sustainable large-volume tumor treatment;Nature Communications;2024-08-13

4. Bispecific antibody drug conjugates: Making 1+1>2;Acta Pharmaceutica Sinica B;2024-05

5. Surface Engineering of Metal-Organic Framework Nanoparticles-Based Mirna Carrier: Boosting Rna Stability, Intracellular Delivery and Synergistic Therapy;2024